Lynx1 Capital Management as of Dec. 31, 2021
Portfolio Holdings for Lynx1 Capital Management
Lynx1 Capital Management holds 10 positions in its portfolio as reported in the December 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Merus N V (MRUS) | 21.7 | $25M | 783k | 31.80 | |
| Travere Therapeutics (TVTX) | 20.0 | $23M | 737k | 31.04 | |
| Alpine Immune Sciences (ALPN) | 15.2 | $18M | 1.3M | 13.85 | |
| Bellus Health Com New | 14.1 | $16M | 2.0M | 8.05 | |
| ImmunoGen | 13.8 | $16M | 2.1M | 7.42 | |
| Pardes Biosciences | 5.7 | $6.6M | 402k | 16.37 | |
| Theseus Pharmaceuticals | 4.5 | $5.2M | 409k | 12.68 | |
| Cymabay Therapeutics | 3.6 | $4.1M | 1.2M | 3.38 | |
| Pieris Pharmaceuticals (PIRS) | 1.3 | $1.4M | 383k | 3.78 | |
| Otonomy | 0.1 | $62k | 30k | 2.07 |
